Literature DB >> 9150119

Hypothesis for the pathogenesis of systemic sclerosis.

D E Furst1, P J Clements.   

Abstract

An hypothesis for the pathogenesis of systemic sclerosis is introduced. It posits a genetic background with environmental stimuli that activate immune cells. The immune cells, in turn, may damage vascular endothelium, cause proliferation of fibroblasts, or stimulate fibroblasts to produce collagen. Endothelial cell damage can also activate the immune system or induce fibroblast proliferation. Associated with fibroblast proliferation may be immune activation or collagen production. Finally, collagen production and end organ damage can induce immune activation thus perpetuating the cycle. Raynaud's phenomenon, an early finding in systemic sclerosis can cause vascular damage, thus entering the cycle at a different point than other environmental stimuli. This hypothesis will undoubtedly require change as data emerge, but it presents a conceptual model for testing and modification.

Entities:  

Mesh:

Year:  1997        PMID: 9150119

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  13 in total

1.  High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.

Authors:  Peter A McSweeney; Richard A Nash; Keith M Sullivan; Jan Storek; Leslie J Crofford; Roger Dansey; Maureen D Mayes; Kevin T McDonagh; J Lee Nelson; Theodore A Gooley; Leona A Holmberg; C S Chen; Mark H Wener; Katherine Ryan; Julie Sunderhaus; Ken Russell; John Rambharose; Rainer Storb; Daniel E Furst
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

Review 2.  Recent advances on pathogenesis and therapies in systemic sclerosis.

Authors:  Norihito Yazawa; Manabu Fujimoto; Kunihiko Tamaki
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

3.  What does the clinician need to improve patient care in systemic sclerosis?

Authors:  Madelon C Vonk; Frank H J van den Hoogen; Piet L C M van Riel; Gabriele Valentini
Journal:  Ann Rheum Dis       Date:  2007-09       Impact factor: 19.103

4.  Skin fibrosis correlates with circulating thyrotropin levels in systemic sclerosis: translational association with Hashimoto's thyroiditis.

Authors:  Gian Luca Bagnato; William Neal Roberts; Alessia Fiorenza; Chiara Arcuri; Rosaria Certo; Francesco Trimarchi; Rosaria Maddalena Ruggeri; Gian Filippo Bagnato
Journal:  Endocrine       Date:  2015-05-21       Impact factor: 3.633

5.  Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosis.

Authors:  T Bohgaki; Y Amasaki; N Nishimura; M Bohgaki; Y Yamashita; M Nishio; K-I Sawada; S Jodo; T Atsumi; T Koike
Journal:  Ann Rheum Dis       Date:  2005-08       Impact factor: 19.103

6.  Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease.

Authors:  Yunliang Chen; Xu Shi-Wen; Jonathan van Beek; Laura Kennedy; Marilyn McLeod; Elisabetta A Renzoni; George Bou-Gharios; Sarah Wilcox-Adelman; Paul F Goetinck; Mark Eastwood; Carol M Black; David J Abraham; Andrew Leask
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

7.  Increased transendothelial migration of scleroderma lymphocytes.

Authors:  G H Stummvoll; M Aringer; J Grisar; C W Steiner; J S Smolen; R Knobler; W B Graninger
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

8.  Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis.

Authors:  K Yanaba; K Takehara; S Sato
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

9.  A nuclear target for interleukin-1alpha: interaction with the growth suppressor necdin modulates proliferation and collagen expression.

Authors:  Bo Hu; Shuhui Wang; Yingze Zhang; Carol A Feghali; Jeffrey R Dingman; Timothy M Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-11       Impact factor: 11.205

Review 10.  Abnormal B lymphocyte activation and function in systemic sclerosis.

Authors:  Ayumi Yoshizaki; Shinichi Sato
Journal:  Ann Dermatol       Date:  2015-02-03       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.